...
首页> 外文期刊>International Journal of Biomedical Science >Characterization of Molecular Evolution in Multi-Drug Resistant of Mycobacterium tuberculosis by rpoB Gene in Patient with Active Pulmonary Tuberculosis from Iranian Isolates
【24h】

Characterization of Molecular Evolution in Multi-Drug Resistant of Mycobacterium tuberculosis by rpoB Gene in Patient with Active Pulmonary Tuberculosis from Iranian Isolates

机译:来自伊朗分离株的活动性肺结核患者中的rpoB基因表征结核分枝杆菌多药耐药分子进化

获取原文
获取原文并翻译 | 示例
           

摘要

This is the first genetic biodiversity study of Mycobacterium tuberculosis in Iran. Thus, we investigatedthe genetic patterns of strains isolated in the first survey of anti-tuberculosis drug-resistance by rpoB geneas part of the Global Project of Anti-tuberculosis Drug Resistance Surveillance (IAU, Iran). A 411-bp frag-ment of the rpoB gene, containing the sequence of the 81-bp rpoB fragment, was amplified by PCR and therpoB gene fragments of tuberculosis strains were sequenced using the Amersham auto sequencer. For ana-lysing tree evolution used method UPGMA and Neighbour-Joining. Clinical isolates (34/163) were analyzedby using sequencing gene rpoB and genotyped by program MEGA. The results were compared with theinternational database. Multi-drug resistant (MDR) was 14% in never treated patients and 8% in previ-ously treated patients. Mutations in rpoB gene and katG genes were detected in 95% and 84% of the MDRstrains, respectively. Two clusters were found to be identical by the four different analysis methods, pre-sumably representing cases of recent transmission of MDR tuberculosis. The other strains are divided into2 groups: group A — similar to the standard and Eastern strains (China, Taiwan) and group B — strains ofanother genotype. They are grouped separately on the dendrogram and became prevalent in Iran (they arecalled Iranian residential strains). This study gives a first overview of the M. tuberculosis strains circulatingin Iran during the first survey of anti-tuberculosis drug-resistance. It may aid in the creation of a nationaldatabase that will be a valuable support for further studies.
机译:这是伊朗对结核分枝杆菌的第一个遗传生物多样性研究。因此,我们调查了rpoB基因作为全球抗结核药物耐药性监测全球项目(伊朗IAU)的一部分,在第一次抗结核药物耐药性调查中分离出的菌株的遗传模式。通过PCR扩增了包含81bp rpoB片段序列的rpoB基因的411bp片段,并使用Amersham自动测序仪对肺结核菌株的therpoB基因片段进行了测序。为了分析树的演化,使用了UPGMA和Neighbour-Joining方法。使用测序基因rpoB分析临床分离株(34/163),并通过MEGA程序进行基因分型。将结果与国际数据库进行比较。从未接受治疗的患者中,多药耐药性(MDR)为14%,之前接受治疗的患者中为8%。在95%和84%的MDR菌株中分别检测到rpoB基因和katG基因的突变。通过四种不同的分析方法发现两个聚类相同,大概代表了最近传播的耐多药结核病病例。其他菌株分为2组:A组-与标准和东部菌株(中国,台湾)相似,B组-另一基因型的菌株。它们分别在树状图上分组,并在伊朗流行(它们被称为伊朗居住株)。这项研究首次概述了在伊朗首次进行的抗结核药物耐药性调查期间在伊朗传播的结核分枝杆菌菌株。它可能有助于建立国家数据库,这将为进一步研究提供宝贵的支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号